Clinical Trial Update: Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the pharmacokinetics and clinical response of doxorubicin in patients with Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Meir Medical Center | Conditions: Non-Hodgkin's Lymphoma | Phase 4 | Status: COMPLETED